Nilotinib drug, molecular model. Nilotinib is a drug used for the treatment of chronic myelogenous leukemia (CML), a cancer of the blood. It is a BCR-
Nilotinib drug, molecular model. Nilotinib is a drug used for the treatment of chronic myelogenous leukemia (CML), a cancer of the blood. It is a BCR-ABL inhibitor that works by blocking a tyrosine kinase enzyme. It is similar to the other CML drug imatinib, but with greater potency and used for drug-resistant forms of CML. It has been approved for use in the USA since 2007. The molecular formula is: Atoms (spheres) are colour-coded: carbon (light grey), hydrogen (white), fluorine (green), nitrogen (blue), and oxygen (red).
Size: 4679px × 3744px
Photo credit: © RAMON ANDRADE 3DCIENCIA/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No
Keywords: -kit, 1, amn107, anti-cance, artwork, background, bcr-abl, blast, cancer, chemical, chemistry, chemotherapy, chronic, chronic-phase, cml, crisis, cut, cut-, cut-outs, cutout, cutouts, dasatinib, ddr1, ddr2, drug, enzymes, epha3, epha8, ephrin, graphic, hematologic, illustration, imatinib, inhibitor, jak, janus, kinase, kit, lck, leukaemia, leukemia, leukemic, lymphoid, mapk11, medical, medicine, model, molecular, molecule, myelogenous, myelosuppression, nilotinib, oncology, outs, pdgfrb, ph-positive, receptors, resistance, resistant, single, space-fill, space-filled, spacefill, spacefilled, src, tasigna, treatment, tumors, tyrosine, white, zak.
